These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 16154477)

  • 1. A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis.
    Passalacqua G; Canonica GW
    Clin Ther; 2005 Jul; 27(7):979-92. PubMed ID: 16154477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
    Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK
    Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
    Devillier P; Roche N; Faisy C
    Clin Pharmacokinet; 2008; 47(4):217-30. PubMed ID: 18336052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desloratadine and levocetirizine improve nasal symptoms, airflow, and allergic inflammation in patients with perennial allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Civardi E; Barberi S; Allen M; Marseglia GL
    Int Immunopharmacol; 2005 Dec; 5(13-14):1800-8. PubMed ID: 16275616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
    Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
    J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis.
    Ciebiada M; Górska-Ciebiada M; DuBuske LM; Górski P
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):664-71. PubMed ID: 17165277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine.
    Frossard N; Strolin-Benedetti M; Purohit A; Pauli G
    Br J Clin Pharmacol; 2008 Feb; 65(2):172-9. PubMed ID: 17953719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of levocetirizine.
    Ferrer M
    Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):1035-47. PubMed ID: 21639816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours.
    Passalacqua G; Guerra L; Compalati E; Massacane P; Rogkakou A; Zanella C; Baena-Cagnani R; Canonica GW
    Int Arch Allergy Immunol; 2004 Oct; 135(2):143-7. PubMed ID: 15345913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levocetirizine improves nasal obstruction and modulates cytokine pattern in patients with seasonal allergic rhinitis: a pilot study.
    Ciprandi G; Cirillo I; Vizzaccaro A; Tosca MA
    Clin Exp Allergy; 2004 Jun; 34(6):958-64. PubMed ID: 15196286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levocetirizine: a new selective H1 receptor antagonist for use in allergic disorders.
    Day JH; Ellis AK; Rafeiro E
    Drugs Today (Barc); 2004 May; 40(5):415-21. PubMed ID: 15319796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative activity of cetirizine and desloratadine on histamine-induced wheal-and-flare responses during 24 hours.
    Purohit A; Melac M; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):635-40. PubMed ID: 15237765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levocetirizine: The latest treatment option for allergic rhinitis and chronic idiopathic urticaria.
    Dubuske LM
    Allergy Asthma Proc; 2007; 28(6):724-34. PubMed ID: 18201439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin.
    Denham KJ; Boutsiouki P; Clough GF; Church MK
    Inflamm Res; 2003 Oct; 52(10):424-7. PubMed ID: 14520518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The place of new antihistamines in allergy management. Apropos of desloratadine].
    Sabbah A
    Allerg Immunol (Paris); 2002 Dec; 34(10):377-83. PubMed ID: 12575624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
    Kłos K; Kruszewski J; Kruszewski R; Sułek K
    Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
    Grant JA; Riethuisen JM; Moulaert B; DeVos C
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rupatadine in allergic rhinitis and chronic urticaria.
    Mullol J; Bousquet J; Bachert C; Canonica WG; Gimenez-Arnau A; Kowalski ML; Martí-Guadaño E; Maurer M; Picado C; Scadding G; Van Cauwenberge P
    Allergy; 2008 Apr; 63 Suppl 87():5-28. PubMed ID: 18339040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.